Cargando…

Awareness of adverse effects of Azathioprine in patients with Inflammatory Bowel Disease – more to be done?

Detalles Bibliográficos
Autores principales:	Spence, Andrew David Roy, Lee, Regina, Keegan, D, Doherty, GA, Mulcahy, H, Murphy, Seamus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Ulster Medical Society 2014
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992102/ https://www.ncbi.nlm.nih.gov/pubmed/24757277

Ejemplares similares

Adverse Events Associated with Azathioprine Treatment in Korean Pediatric Inflammatory Bowel Disease Patients
por: Chun, Ji Young, et al.
Publicado: (2013)

An unusual adverse event of azathioprine: Cutaneous small vessel vasculitis
por: Hanai, Shunichiro, et al.
Publicado: (2021)

Azathioprine in inflammatory bowel disease, a safe alternative?
por: Tanis, A A
Publicado: (1998)

Monitoring and Safety of Azathioprine Therapy in Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2013)

Not everything that can be done should be done
por: Slagt, Cor
Publicado: (2016)

Why more research needs to be done on echinococcosis in Pakistan
por: Ahmed, Haroon, et al.
Publicado: (2017)

Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
por: van Liere, Elsa L. S. A., et al.
Publicado: (2021)

Change in Hematologic Indices over Time in Pediatric Inflammatory Bowel Disease Treated with Azathioprine
por: Soman, Sherman, et al.
Publicado: (2012)

The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease
por: Vögelin, Marius, et al.
Publicado: (2016)

Real-World Use of Azathioprine Metabolites Changes Clinical Management of Inflammatory Bowel Disease
por: Wilson, Laura, et al.
Publicado: (2020)

Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study
por: Crepaldi, Martina, et al.
Publicado: (2023)

Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease
por: Suzuki, Shizuka, et al.
Publicado: (2023)

Azathioprine is More Effective than Mesalazine at Preventing Recurrent Bowel Obstruction in Patients with Ileocecal Crohn’s Disease
por: Vidigal, Fernando Mendonça, et al.
Publicado: (2014)

Pulmonary Hypertension: More To Be Done
por: Idrees, Majdy M
Publicado: (2009)

More to be done for the older patients
por: Koo, Bon-Nyeo
Publicado: (2020)

Twin Pregnancies—More to Be Done
por: Anteby, Matan, et al.
Publicado: (2022)

Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study
por: Alsous, Mervat M., et al.
Publicado: (2020)

Usefulness of Measuring Thiopurine Metabolites in Children with Inflammatory Bowel Disease and Autoimmunological Hepatitis, Treated with Azathioprine
por: Bąk-Drabik, Katarzyna, et al.
Publicado: (2021)

CHYLOUS PERITONITIS WITH SMALL BOWEL OBSTRUCTION
por: Murugan, Krithika, et al.
Publicado: (2008)

No Harm Done?
por: Crawford, Mike
Publicado: (1999)

Rewriting Evolution—“Been There, Done That”
por: Penny, David
Publicado: (2013)

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity
por: Teich, Niels, et al.
Publicado: (2016)

Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study
por: Fangbin, Zhang, et al.
Publicado: (2016)

Azathioprine dosing and metabolite measurement in pediatric inflammatory bowel disease: does one size fit all?
por: Walker, Rebecca, et al.
Publicado: (2019)

Azathioprine Has a Deleterious Effect on the Bone Health of Mice with DSS-Induced Inflammatory Bowel Disease
por: Morgan, Stephanie, et al.
Publicado: (2019)

Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience
por: Yewale, Rohan V, et al.
Publicado: (2023)

Biodegradable Iron-Based Materials—What Was Done and What More Can Be Done?
por: Gąsior, Gabriela, et al.
Publicado: (2021)

Construction industry: More needs to be done
por: Kulkarni, G. K.
Publicado: (2007)

There is one more thing to be done: ECMO!
por: Antoniali, Fernando
Publicado: (2015)

A lot is done and more will come
por: Kagan, Karl Oliver
Publicado: (2022)

The Clinical Efficacy of Azathioprine in Korean Patients with Atopic Dermatitis
por: Lee, Hemin, et al.
Publicado: (2015)

Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound
por: Barnhoorn, Marieke C, et al.
Publicado: (2021)

Tobacco use among Australian dental hygiene students is declining, but more still needs to be done
por: Hayes, Melanie J, et al.
Publicado: (2013)

Mental health during the coronavirus disease 2019 (Covid-19) pandemic: more is still to be done
por: Endomba, Francky Teddy, et al.
Publicado: (2020)

Nonmelanoma skin cancer risk awareness in azathioprine‐treated myasthenia gravis patients
por: McGurgan, Iain J., et al.
Publicado: (2015)

Commensal bacteria promote azathioprine therapy failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailability
por: Yan, Yuqing, et al.
Publicado: (2023)

Association Between Genetically Predicted Expression of TPMT and Azathioprine Adverse Events
por: Davis, Alyssa, et al.
Publicado: (2023)

Azathioprine treatment in two children with Henoch–Schönlein purpura nephritis
por: Melikoğlu, Meltem A., et al.
Publicado: (2017)

Good Work Done and More to Follow at Leicester
Publicado: (1914)

Increased research productivity in Nigeria: more to be done
por: Odeyemi, Olumide Adedokun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i5m67egvooh8o02orf0e175mi2